Cane Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cane Capital Partners's AMGN Position: Q3 2026 in Review
Cane Capital Partners reduced its Amgen (AMGN) stake by 25% in Q3 2026, selling an estimated $329K and leaving 2,433 shares worth $1.03M. The position accounts for 0.38% of the portfolio, ranked #59.
Cane Capital Partners first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.18M in Q2 2026. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Cane Capital Partners held 2,433 shares of Amgen worth $1.03M as of Q3 2026.
- Cane Capital Partners sold 826 Amgen shares in Q3 2026, an estimated $329K.
- Amgen made up 0.38% of Cane Capital Partners's portfolio in Q3 2026, its #59 holding.
- Cane Capital Partners first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
- Cane Capital Partners's Amgen position peaked at $1.18M in Q2 2026.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.